Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Soticlestat as an adjunctive therapy in children and young adults with Dravet syndrome.
Journal: Epilepsia
Published: October 16, 2025
Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1.
Journal: The New England journal of medicine
Published: May 14, 2025
TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy Men.
Journal: Anesthesiology
Published: January 13, 2025
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1.
Journal: The New England journal of medicine
Published: July 26, 2023
Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.
Journal: Journal of medicinal chemistry
Published: July 23, 2020
Targeting Huntingtin in Patients with Huntington's Disease.
Journal: The New England journal of medicine
Published: September 19, 2019
Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia.
Journal: Brain : a journal of neurology
Published: May 16, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.
Journal: The Lancet. Neurology
Published: January 15, 2019
Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971].
Journal: Clinical therapeutics
Published: March 11, 2018
The exciting field of neuro-repair in multiple sclerosis: an interview with Sarah I Sheikh.
Journal: Neurodegenerative disease management
Published: February 01, 2018
A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries.
Journal: BMC neurology
Published: July 27, 2017
Last Updated: 09/26/2026